A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses.
Ehsan IrajizadChae Young HanJoseph CelestinoRanran WuEunice MurageRachelle SpencerJennifer B DennisonJody V VykoukalJames P LongKim-Anh DoCharles W DrescherKaren H LuZhen LuRobert C BastSamir M HanashJohannes F FahrmannPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
A blood-based metabolite panel was developed that demonstrates independent predictive ability and complements ROMA for distinguishing early-stage ovarian cancer from benign disease to better inform clinical decision making.